Manguda, Amyra .
HRN: 00-28-18 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/24/2025
CEFUROXIME 500MG (TAB)
01/24/2025
01/30/2025
ORAL
500 Mg
BID
Sp NSVD With RMLE + Repair
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes